Associated Papers
Givosiran in acute intermittent porphyria: A personalized medicine approach.
Poli A et al.
Molecular Genetics and Metabolism, 2022
Kidney Involvement in Acute Hepatic Porphyrias: Pathophysiology and Diagnostic Implications.
Ricci A et al.
Diagnostics (basel, Switzerland), 2021
A Variant of Peptide Transporter 2 Predicts the Severity of Porphyria-Associated Kidney Disease.
Tchernitchko D et al.
Journal of the American Society of Nephrology : Jasn, 2017
High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria.
Pallet N et al.
Kidney International, 2015
Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families.
Kauppinen R et al.
Clinical Chemistry, 2002
Select a paper to view details